Impact of perioperative chemotherapy on Nigerian patients with locally advanced and metastatic gastric cancer.

e15180 Background: The overall 5-year survival of patients with gastric cancer is only 14% in Nigeria as compared to 23% in the United States of America and 60% in Japan [1-3]. The possible reasons...